Long-acting injectable paliperidone palmitate in a haemodialysis patient with schizophrenia

Aust N Z J Psychiatry. 2021 Aug;55(8):829-830. doi: 10.1177/0004867420952548. Epub 2020 Aug 27.

Authors

Jia-Hong Lin¹, Tsung-Huang Tsai², Chia-Shun Lee², Ya-Hui Yang², Kuang-Peng Chen², Chun-Liong Tung², Jui-Hsiu Tsai^{2

3}

Affiliations

¹ Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan.
² Department of Psychiatry, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan.
³ PhD Program in Environmental and Occupational Medicine, National Health Research Institutes and Kaohsiung Medical University, Kaohsiung, Taiwan.

PMID: 32847372
DOI: 10.1177/0004867420952548

No abstract available

Publication types

Letter

MeSH terms

Antipsychotic Agents* / therapeutic use
Delayed-Action Preparations / therapeutic use
Hospitalization
Humans
Paliperidone Palmitate
Renal Dialysis
Schizophrenia* / drug therapy

Substances

Antipsychotic Agents
Delayed-Action Preparations
Paliperidone Palmitate